Sorrento Therapeutics, Inc.
SEC CIK 850261 · EDGAR
BoughtSold
Most active insiders at CELU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LeVien Vincent | Dir | — | — |
| 2 | Brigido Stephen | Pres, Functional Regeneration | — | — |
| 3 | Haines John R | Senior Exec VP | — | — |
| 4 | Ling Geoffrey M.D. | Dir | — | — |
| 5 | Parks Diane L. | Dir | — | — |
| 6 | Diamandis Peter | Dir | — | — |
| 7 | Hariri Robert J | CEO, Dir | — | — |
Sorrento Therapeutics, Inc. made no open-market trades at CELU in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-05 | 2023-09-29+ | CELU | Celularity Inc | Sorrento Therapeutics, Inc. | 10% | S - Sale | — | -15.37M | 11.36M | -58% | — |
| D | 2023-09-25 | 2023-09-21 | SCLX | Scilex Holding Co | Sorrento Therapeutics, Inc. | 10% | S - Sale | — | -60.07M | 1.92M | -97% | — |
| 2023-01-23 | 2023-01-19 | SCLX | Scilex Holding Co | Sorrento Therapeutics, Inc. | 10% | J - Other | $0.00 | -73.74M | 61.99M | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations